DEA Adopts Provisions to Expand Access to Medication-Assisted Treatment

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Opioid Use Disorder

DEA Adopts Provisions to Expand Access to Medication-Assisted Treatment

Joan Flynn

January 23, 2018 at 21:41:41 ET

The Drug Enforcement Administration published a final rule implementing a 2016 law that expanded the types of practitioners who may, under certain conditions and on a temporary basis, dispense a narcotic drug in Schedule III, IV or V for the purpose of maintenance treatment or detoxification treatment (83 Fed. Reg. 3071; Jan. 23, 2018). The final rule also amends the Controlled ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Adopts Provisions to Expand Access to Medication-Assisted Treatment

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT